NMC.L

NMC Health Plc
FTSE Russell - NMC Health
9th April 2020, 17:35
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4487J
FTSE Russell
09 April 2020
 

 

 


 

 

NMC Health (UK): Continued Suspension - Update

Informative Notice

09 April 2020

FTSE Russell notes the announcement regarding the appointment of administrators for NMC Health (UK, B7FC076, FTSE 100 Index, GEIS Mid Cap) and its continuing suspension. FTSE Russell will continue to monitor and if a cancellation of listing is confirmed then the company will be removed from the FTSE Russell indexes with the provision of two days' notice. 

FTSE Russell intends to remove NMC Health at a nominal value (GBX 0.0001).

Please contact your Client Service representative if you have any questions or comments for consideration.

Further notices will be published in due course.

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

                                   

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSKKCBBOBKDAQK ]]>
TwitterFacebookLinkedIn